[1] |
Shroff N A, Balbin J, Shobitan O. High-altitude illness: updates in prevention, identification, and treatment[J]. Emerg Med Pract,2021,23(9):1-24.
|
[2] |
Richalet J P, Larmignat P, Poitrine E, et al. Physiological risk factors for severe high-altitude illness: a prospective cohort study[J]. Am J Respir Crit Care Med, 2012, 185(2):192-198.
|
[3] |
Wu T Y, Ding S Q, Liu J L, et al. Who are more at risk for acute mountain sickness: a prospective study in Qinghai-Tibet railroad construction workers on Mt. Tanggula[J]. Chin Med J, 2012, 125(8):1393-1400.
|
[4] |
Guo W Y, Bian S Z, Zhang J H, et al. Physiological and psychological factors associated with onset of high-altitude headache in Chinese men upon acute high-altitude exposure at 3700 m[J]. Cephalalgia, 2017, 37(4):336-347.
|
[5] |
Boos C J, Bass M, O’Hara J P, et al. The relationship between anxiety and acute mountain sickness[J]. PLoS One, 2018, 13(6):e0197147.
|
[6] |
Fiore D C, Hall S, Shoja P: Altitude illness: risk factors, prevention, presentation, and treatment[J]. Am Fam Physician, 2010, 82(9):1103-1110.
|
[7] |
牛文忠, 范泉水, 殷旭东, 等. 急进高原劳动作业预防急性高原病的措施探讨[J].西南国防医药, 2012, 22(12):1373-1375.
|
[8] |
Luks A M, Swenson E R, Bärtsch P. Acute high-altitude sickness [J]. Eur Respir Rev, 2017, 26(143): 160096.
|
[9] |
Beidleman B A, Fulco C S, Cymerman A, et al. New metric of hypoxic dose predicts altitude acclimatization status following various ascent profiles[J]. Physiol Rep, 2019, 7(20):e14263.
|
[10] |
Wu T Y, Ding S Q, Liu J L, et al. Reduced incidence and severity of acute mountain sickness in Qinghai-Tibet railroad construction workers after repeated 7-month exposures despite 5-month low altitude periods[J]. High Alt Med Biol, 2009, 10(3):221-232.
|
[11] |
Dehnert C, Böhm A, Grigoriev I, et al. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study[J]. Wilderness Environ Med, 2014, 25(3):263-271.
|
[12] |
Molano Franco D, Nieto Estrada V H, Gonzalez Garay A G, et al. Interventions for preventing high altitude illness: Part 3. Miscellaneous and non-pharmacological interventions[J]. Cochrane Database Syst Rev, 2019, 4(4):Cd013315.
|
[13] |
包政权, 张 侠, 李丁有, 等. 训练性心理治疗结合音乐疗法预防高原病的效果[J]. 中国心理卫生杂志, 2011, 25(9):658-659.
|
[14] |
Nieto Estrada V H, Molano Franco D, Medina R D, et al. Interventions for preventing high altitude illness: Part 1. Commonly-used classes of drugs[J]. Cochrane Database Syst Rev,2017, 6(6):Cd009761.
|
[15] |
Luks A M, Auerbach P S, Freer L, et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update[J]. Wilderness Environ Med, 2019, 30(4s):S3-s18.
|
[16] |
Joyce K E, Lucas S J E, Imray C H E, et al. Advances in the available non-biological pharmacotherapy prevention and treatment of acute mountain sickness and high altitude cerebral and pulmonary oedema[J]. Expert Opin Pharmacother, 2018, 19(17):1891-1902.
|
[17] |
Gertsch J H, Corbett B, Holck P S, et al. Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness[J]. Wilderness Environ Med,2012, 23(4):307-315.
|
[18] |
Lipman G S, Kanaan NC, Holck P S, et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories[J]. Ann Emerg Med, 2012, 59(6):484-490.
|
[19] |
Burns P, Lipman G S, Warner K, et al. Altitude sickness prevention with ibuprofen relative to acetazolamide[J]. Am J Med, 2019, 132(2):247-251.
|
[20] |
Sydykov A, Mamazhakypov A, Maripov A, et al. Pulmonary hypertension in acute and chronic high altitude maladaptation disorders[J]. Int J Environ Res Public Health, 2021,18(4):1692.
|
[21] |
Yang B, Wang G Y, Chen B, et al. Anti-hypoxia and anti-oxidation effects of aminophylline on human with acute high-altitude exposure[J]. Chin Med Sci J,2007, 22(1):62-65.
|
[22] |
Yang J, Zhang L, Liu C, et al. Trimetazidine attenuates high-altitude fatigue and cardiorespiratory fitness impairment: a randomized double-blinded placebo-controlled clinical trial[J].Biomed Pharmacother,2019, 116:109003.
|
[23] |
Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema[J]. N Engl J Med, 2002, 346(21):1631-1636.
|
[24] |
Li Z, Guo J, Liu C, et al. Compound Danshen dripping pill promotes adaptation to acute high-altitude exposure[J]. High Alt Med Biol,2020,21(3):258-264.
|
[25] |
曹富丽. 急性高原反应预防用药的研究[D].重庆:第三军医大学,2016.
|
[26] |
齐 跃, 符 婷, 房加雄, 等. 红景天预防急性高原反应的系统评价[J].武警后勤学院学报(医学版), 2016, 25(1):41-44.
|
[27] |
Chiu T F, Chen L L, Su D H, et al. Rhodiola crenulata extract for prevention of acute mountain sickness: a randomized, double-blind, placebo-controlled, crossover trial[J]. BMC Complement Altern Med,2013, 13:298.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2017, 28(12): 1282-1285. |
|
|
|